Takara Bio Inc.

TSE:4974.T

1008 (JPY) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 1,48121,22427,53213,5525,4334,8233,3612,8052,9052,4812,1852,2681,66297869799671375-1,252-888
Depreciation & Amortization 5,0214,7354,1493,7863,5303,3753,2172,0492,0671,6721,4671,5111,5441,6671,8512,0732,1572,4122,0511,778
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital -3,90220,602-19,266-1,702-2,345-1,887-1,804-682-946235-703-1,254-605-201284519-1587-699355
Accounts Receivables 1,5015,718-4,812-3,559-579-974-246-720-165-2644-29000000000
Inventory -32413,510-14,233-1,767-974-1,536-301-594-600110-461-149-259103216-383260439-240229
Accounts Payables -928139-4311,016-468-199-341288-20200000000000
Other Working Capital -4,1511,2352102,608-324822-1,503-88-346125-242-1,105-346-30468902-261148-459126
Other Non Cash Items 8,904-9,664-5,430-1,693-279-528-839-588-1,005-830-698-299-235-351342-426-809-246526-90
Operating Cash Flow 1,71136,8976,98513,9436,3395,7833,9353,5843,0213,5582,2512,2262,3662,0933,1742,2652,0183,1286261,155
Investing Activities:
Investments In Property Plant And Equipment -12,778-5,882-12,539-8,845-4,052-6,082-1,592-1,517-2,374-4,891-5,713-2,503-1,011-1,181-1,346-1,053-1,833-889-1,504-2,135
Acquisitions Net 93964714-3,661764-12,39600-2760014700071725100
Purchases Of Investments -2,224-17,769-11,406-2,613-10,785-18,667-16,383-12,802-19,926-28,645-35,616-22,227-957-5260-909-105-245-7,333-50
Sales Maturities Of Investments 2,93716,55412,8775,76614,51518,39514,86028,07118,12530,64526,71822,71395705774392,3287860849
Other Investing Activites -98683,9501,9003,77114756-259-2-1131-62333-3,932-6,291-3,988-429-335-50215
Investing Cash Flow -13,043-6,693-7,071-3,778-212-5,576-14,75513,493-4,177-3,168-14,480-2,079-531-5,639-7,060-5,511678-432-9,339-1,321
Financing Activities:
Debt Repayment -181-151-147000-677-47-47-47-66-59-45-45-45-44-44-44-818-150
Common Stock Issued 000000000011,40132441292535894734597,477
Common Stock Repurchased 0000000000520000-15100-30
Dividends Paid -5,052-3,968-1,923-962-841-541-480-216-180-143-123-11100000000
Other Financing Activities -181-151-147-141-1050-48-176-4117-51-44-37170-399,921-116
Financing Cash Flow -5,233-4,119-2,070-1,103-946-541-1,205-280-221-23111,281149-4-60-57-168453904,5997,211
Other Information:
Effect Of Forex Changes On Cash 6788131,008-215-182-252-123-166-125481839437-74-16648-339-289516215
Net Change In Cash -15,88726,898-1,1488,8464,998-587-12,14916,632-1,503641-1087351,756-3,772-3,896-3,7542,7143,181-3,9517,060
Cash At End Of Period 33,17149,05822,16023,30814,4629,46410,05122,2005,5687,0716,4306,5385,8034,0477,81911,71515,46915,9369,57313,524